FILLUNAR
Live / Registered — Registered (as of 02 Jun 2026)
What this means for you
Registered since 02 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2032: the §71 affidavit of use).
Record
- Serial number
- 79428897
- Registration number
- 8278998
- Mark type
- Word mark
- Filed
- 13 May 2025
- Published for opposition
- 14 Apr 2026
- Registered
- 02 Jun 2026
- Next maintenance filing
- §71 affidavit of use, due by 02 Jun 2032 (grace period to 02 Dec 2032)
- Attorney of record
- Brian P. Gregg
Goods and services
- Class 005 — Pharmaceuticals: Antiseptic preparations; medical hyaluronic acid in ampoule form for pharmaceutical purposes; drug delivery agents in the form of lyophilized formulations that facilitate the delivery of pharmaceutical preparations for the treatment of facial wrinkles and volume enhancement; medical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; chemical preparations for pharmaceutical use, namely, for skin wrinkles and facial volume loss using drug delivery systems; cells for medical purposes; reagents for medical use; pharmaceutical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; diagnostic preparations for medical purposes; medical anti-aging serum; viscous fillers for wrinkle filling or volume augmentation being medical skin grafts; nucleic acid for medical purposes; medical hyaluronic acid preparations for pharmaceutical purposes; pharmaceutical skin lotions; pharmaceutical preparations for skin wrinkles and facial volume loss using drug delivery systems; surgical transplants comprising living tissues; pharmaceutical preparations for the treatment and prevention of skin wrinkles and facial volume loss using drug delivery systems; natural biomaterials for tissue recovery for medical purposes; pharmaceutical preparations for the treatment of wrinkles; injectable medical preparations for wrinkle filling in the form of gels; injectable dermal fillers for the treatment of wrinkles in the form of gels; injectable dermal fillers; injectable pharmaceuticals for treatment of skin wrinkles and facial volume loss using drug delivery systems; injectable dermal fillers for the treatment of forehead lines, glabellar lines, temple lines, cheek volume loss, cheekbone volume loss, nasolabial folds lines, marionette lines, lip lines; pharmaceutical preparation for skin care; bandages for skin wounds; pharmaceutical preparation for scar treatment
Owner
- BIONT Co., Ltd., KR
- BIONT Co., Ltd., KR
- BIONT Co., Ltd., KR
Prosecution history
- 02 Sept 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 14 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Apr 2026 — PUBLISHED FOR OPPOSITION
- 08 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 09 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 09 Feb 2026 — FINAL REFUSAL E-MAILED
- 09 Feb 2026 — FINAL REFUSAL WRITTEN
- 07 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE